February 2008: Dr. Terri Bonenberger, DVM, ACVD Joins KBVC Dept. of Dermatology

We welcome the skills and interests Dr. Bonenberger brings to KBVC for the benefit of our patients.
Terri has a strong background in treating ear disease, allergic disease and dermatopathology.
She has worked closely with both veterinary surgeons and radiologists in the management and
understanding of chronic ear disease.

Dr. Bonenberger is actively involved in the ACVD and is a member of the International Society of
Veterinary Dermatopathology. She has published numerous scientific articles and lectures nationally.

October 2007: KBVC Welcomes Dr. Pierre Amsellem, Doct. Vet., MS, DACVS

Dr. Pierre Amsellem is a diplomate of the American College of Veterinary Surgeons.
He is originally from Paris, France, where he attended veterinary school and graduated
in 1999. Dr. Amsellem then pursued extensive training in the U.S. to specialize
in veterinary surgery, completing a small animal rotating internship at Purdue University
and a three-year residency in small animal surgery at Colorado State University.

Following his residency, Pierre worked as a surgeon in an Emergency and Surgical
Referral practice in Florida. Dr. Amsellem is skilled in all areas of veterinary surgery
including orthopedic, soft tissue, oncologic and neurosurgery. He also performs
minimally invasive procedures such as laparoscopy and arthroscopy. He has authored
several articles on intervertebral disk disease and biliary surgery, and a book chapter
on liver surgery.

We look forward to Dr. Amsellem adding to the knowledge and skill of KBVC’s Department
of Surgical Services led by Dr. Robert C. Hart.

June 2007: Dr. Philip J. Bergman, DVM Joins BrightHeart as Chief Medical Officer

Philip J. Bergman, DVM, PhD, MS, DACVIM, has joined BrightHeart as Chief
Medical Officer. He will be responsible for all aspects of veterinary medicine
within the organization, with oversight of each facility's medical practices and
performance.

Dr. Bergman is one of the nation's leading veterinary oncologists. He is board
certified in oncology by the American College of Veterinary Internal Medicine,
and earned a PhD in human cancer biology from the M.D. Anderson Cancer
Center in Houston, where he was awarded an American Cancer Society
Physician Research Training Fellowship. Dr. Bergman became head of the
Donaldson-Atwood Cancer Clinic at the Animal Medical Center in New York in
1999, and director of the Flaherty Comparative Oncology Laboratory in 2001.
He currently holds an adjunct faculty membership with the human cancer
center at Memorial Sloan-Kettering Cancer Center in New York.

Dr. Bergman's accomplishments in veterinary medicine and veterinary
research have been widely recognized. In 2003, he received the Hill's Award
for Excellence in Veterinary Healthcare at the WSAVA Congress, and in 2005,
he was elected to the American College of Veterinary Internal Medicine Board
of Regents. In collaboration with Memorial Sloan-Kettering Cancer Center and
Merial, Inc., an international animal health company, Dr. Bergman developed
a canine melanoma vaccine that was granted conditional licensure by the U.S.
Department of Agriculture earlier this year, the first U.S. government
approved vaccine of any kind for the treatment of cancer. Dr.Bergman will
continue his work with this investigational vaccine program at BrightHeart,
seeking to extend its applicability to canine lymphoma, breast cancer and
other tumors.

December 2006: KBVC Welcomes Joseph A. Impellizeri, DVM, ACVIM, Oncology

The arrival of Dr. Joseph Impellizeri at the Katonah Bedford Veterinary Center
marks a significant addition to our established Department of Oncology. His
areas of expertise strategically enhance the diagnostic and surgical skills offered
at KBVC in this highly specialized field. Dr. Impellizeri offers the latest advances
in chemotherapy protocols, pain management, cancer immunotherapy (tumor
vaccines), laparoscopic/thorascopic procedures, ultrasound and CT and MRI
diagnostic imaging. Dr. Impellizeri has participated in clinical trials with the
Animal Cancer Institute plus collaborative research studies with Vassar College.